GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Tumor necrosis factor ligand superfamily member 15, membrane form
                                 Compound class: 
                                                            Endogenous peptide in human, mouse or rat
                                 
                                    
                                        Comment: TL1A occurs as both membrane‐bound and soluble forms. It principally functions as a negative modulator of epithelial cell proliferation. Inhibiting the TL1A/death receptor 3 (TNFRSF25) pathway has been proposed as mechanism to treat inflammatory bowel disease [1]. In addition, TL1A has been associated with tumourigenesis and progression of some gastrointestinal malignancies  [3,5,7], making it a target of interest for the development of novel anti-cancer drugs.
                                    
                                 
                                    Species: Human
                                 | 
| Classification  | |
| Compound class | Endogenous peptide in human, mouse or rat | 
| Ligand families/groups | Tumor necrosis factor superfamily ligands | 
| Synonyms  | 
| Tumor necrosis factor ligand superfamily member 15, membrane form | 
| Gene/Precursor  | ||||||||||
| 
 | 
| Database Links  | |
| CATH/Gene3D | 2.60.120.40 | 
| Ensembl Gene | ENSG00000181634 (Hs) | 
| GtoPdb PubChem SID | 178101764 | 
| Human Protein Atlas | ENSG00000181634 (Hs) | 
| UniProtKB | O95150 (Hs) | 
| Wikipedia | TNFSF15 |